313 | Enter in a long play whit UWRL | Mary Johnson | 10/10/2012 8:10:50 AM |
312 | Moving forward | Mary Johnson | 10/10/2012 8:06:34 AM |
311 | ExpotentialMovingAverage and | aleksdavis | 10/10/2012 7:35:54 AM |
310 | When we | aleksdavis | 10/10/2012 7:30:35 AM |
309 | EMA and | aleksdavis | 10/10/2012 7:05:56 AM |
308 | Now is | aleksdavis | 10/10/2012 6:57:33 AM |
307 | Also, | aleksdavis | 10/10/2012 6:50:19 AM |
306 | Looking | mwirmm | 10/09/2012 2:37:10 PM |
305 | UWRL lo | mwirmm | 10/09/2012 2:36:13 PM |
304 | UWRL Ti | mwirmm | 10/09/2012 2:34:55 PM |
303 | keep an eye on it within a couple of | judith keenan | 10/09/2012 2:03:34 PM |
302 | I would buy in this gap if iwasn'talready in | judith keenan | 10/09/2012 1:55:58 PM |
301 | UWRL can be very good play too if | judith keenan | 10/09/2012 12:03:45 PM |
300 | UWRL going up Chart pattern clearly indicates | John Howard | 10/09/2012 12:03:31 PM |
299 | BUYsig | John Howard | 10/09/2012 11:52:51 AM |
298 | UWRL Maximum BUY | John Howard | 10/09/2012 11:38:15 AM |
297 | Conclus | Mary Johnson | 10/09/2012 5:32:51 AM |
296 | You are | Mary Johnson | 10/09/2012 5:25:21 AM |
295 | Any upd | aleksdavis | 10/09/2012 5:02:08 AM |
294 | This is | aleksdavis | 10/09/2012 4:31:20 AM |
293 | 20 - 50 Day MACD Oscillator Buy 20-50 Day MACD | aleksdavis | 10/09/2012 4:24:16 AM |
292 | Im sure | aleksdavis | 10/09/2012 4:18:30 AM |
291 | Price i | aleksdavis | 10/09/2012 4:11:51 AM |
290 | UWRL wi | theellasmith | 10/09/2012 4:05:31 AM |
289 | You are | Mary Johnson | 10/09/2012 4:00:58 AM |
288 | I've se | theellasmith | 10/09/2012 3:55:20 AM |
287 | To find | theellasmith | 10/09/2012 3:51:50 AM |
286 | These a | theellasmith | 10/09/2012 3:47:33 AM |
285 | I prefe | Mary Johnson | 10/09/2012 3:40:33 AM |
284 | Short,medium or long run?However success is | Mary Johnson | 10/09/2012 3:16:00 AM |
283 | Exactly | mwirmm | 10/08/2012 4:04:57 PM |
282 | The definition of the market on which UWRL is | Milly Joel | 10/08/2012 4:01:08 PM |
281 | Nice, t | mwirmm | 10/08/2012 3:44:22 PM |
280 | +7650% Techn | Milly Joel | 10/08/2012 3:40:07 PM |
279 | Excitin | mwirmm | 10/08/2012 3:38:26 PM |
278 | UWRL ha | mwirmm | 10/08/2012 3:38:21 PM |
277 | We'll g | judith keenan | 10/08/2012 1:41:20 PM |
276 | I agree | judith keenan | 10/08/2012 1:09:45 PM |
275 | I hopetheylaunchnews site that would give | judith keenan | 10/08/2012 12:59:55 PM |
274 | Will watch UWRL with interest, looking for | judith keenan | 10/08/2012 12:32:26 PM |
273 | Well, i | judith keenan | 10/08/2012 12:25:52 PM |
272 | I'm expecting a big spike ! | John Howard | 10/08/2012 11:38:27 AM |
271 | UWRL ha | John Howard | 10/08/2012 11:34:58 AM |
270 | UWRL BUY! | John Howard | 10/08/2012 11:32:00 AM |
269 | Update: | aleksdavis | 10/08/2012 7:36:49 AM |
268 | Some in | theellasmith | 10/08/2012 7:29:05 AM |
267 | Expectations for this week? Your opinion about | aleksdavis | 10/08/2012 7:16:29 AM |
266 | Well, U | aleksdavis | 10/08/2012 7:10:40 AM |
265 | That's | theellasmith | 10/08/2012 7:02:48 AM |
264 | Ofc. Re | aleksdavis | 10/08/2012 7:02:20 AM |
Recent Articles
- Exploring the Evolution of Urban-Rural Transport in China
- DDB Capital Enhances Investment Focus in North Alabama Housing
- Anticipation Grows for the 2nd China-Central Asia Summit
- Revitalizing Heritage: A Journey Through Dunhuang's Culture
- Abbisko Therapeutics Advances Irpagratinib Study for HCC Treatment
- China to Host 6th Multinationals Summit, Encouraging Investment
- SDP Japan Secures $31 Million to Transform Surgical Care
- Tokyo Gas Triumphs in Cloud Native Case Study Competition
- Significant Subgroup Analysis of Cadonilimab in Cervical Cancer
- Stavian Chemical Achieves Major Milestone in Global Rankings
- ArkBio's Azstarys Approved for ADHD Treatment Review in China
- Strategic Thinking in China's Development Plans and Governance
- Industrial Lubricants: Insights and Future Market Trends Ahead
- Innovent's Mazdutide Advances with First Patient Dosed in Trial
- Innovative Treatment Strategies Highlighted at EHA 2025 Conference
- Celltrion Gains FDA Nod for New STEQEYMA® Pediatric Formulation
- Innovative Drug Screening Services Introduced by Samsung Biologics
- Transforming Transit: $4 Billion to Electrify Buses in Canada
- Abaxx Technologies Launches Innovative Gold Futures Trading
- 2025 Meijer LPGA Classic Makes Impact with $1.5 Million
- Bombardier's Global 7500 Establishes New Speed Benchmark
- IDEX Biometrics ASA Announces Significant Share Issuance to Personnel
- Investors Urged to Join Class Action Against West Pharmaceutical Services
- Honoring Leonard A. Lauder: A Legacy in Alzheimer's Research
- Elevate Your Earnings with PFMCrypto's Exciting XRP Giveaway
- AIXA Miner Celebrates Groundbreaking Milestone in Green Mining
- Oma Savings Bank Plc Revises Profit Outlook: Important Update
- Transformative Leadership Change at Renault Group Announced
- Deadline for Fortrea Holdings Inc. Investors in Lawsuit Ahead
- Dupixent® Triumphs in Phase 4 Trial Against Xolair® for CRSwNP
- Dupixent vs. Xolair: Breakthrough Findings in Asthma Treatment
- Faruqi & Faruqi Investigates Ibotta's Legal Claims for Investors
- Red Cat Holdings Faces Legal Challenges Amid Investor Concerns
- Investor Alert: Key Updates on Iovance Biotherapeutics Lawsuit
- Investors Alert: Faruqi & Faruqi Advocate for Open Lending Claims
- Compass Diversified Investors Encouraged to Act Before Deadline
- Freedom Holding Corp. Sees Strong Financial Growth in 2025
- Intellia's Lonvo-z Shows Promising Results for HAE Treatment
- Important Update for Rocket Pharmaceuticals Investors
- DoubleVerify Investors Urged to Consider Legal Options Now
- Investing in Zenas BioPharma: What Investors Should Know
- Deadline for NET Power Investors: What's Next After Losses?
- Investors Urged to Act: Krispy Kreme Legal Investigation Update
- Investigating Investor Claims on Avis Budget Group's Financials
- Urgent Investor Insights: Fortrea Holdings Under Scrutiny
- Investor Alert: Examining West Pharmaceutical Services Fraud Claims
- Vital Insights on Napco Security Technologies for Investors
- Urgent Alert: Investors of PepGen Should Act Now
- Critical Update for Civitas Resources Investors Amid Legal Scrutiny
- UroGen Investors Urged to Act Before Class Action Deadline